Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
| Published in: | Immunotherapy Advances |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868553705277620224 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Immunotherapy Advances |
| description | |
| discipline_display | Allergology and Immunology |
| discipline_facet | Allergology and Immunology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:84516 |
| institution | FRELIP |
| journal_source_facet | Immunotherapy Advances |
| last_indexed | 2026-06-20T21:41:14.952Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Neuraminidase A controls pneumococcal recognition and fate: deficiency enhances immune sensing and intracellular survival, while treatment promotes phagocytic clearance. Allergology and Immunology General Allergology and Immunology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Allergology and Immunology General Allergology and Immunology |
| subject_facet | Allergology and Immunology General Allergology and Immunology |
| title | Neuraminidase A controls pneumococcal recognition and fate: deficiency enhances immune sensing and intracellular survival, while treatment promotes phagocytic clearance. |
| title_alt | La neuraminidasa A controla el reconocimiento y destino neumocócico: la deficiencia mejora la detección inmune y la supervivencia intracelular, mientras que el tratamiento promueve la eliminación fagocítica La neuraminidase A contrôle la reconnaissance et le devenir du pneumocoque : la déficience améliore la détection immunitaire et la survie intracellulaire, tandis que le traitement favorise la clairance phagocytaire Neuraminidase A controla o reconhecimento e destino pneumocócico: a deficiência aumenta o reconhecimento imune e a sobrevivência intracelular, enquanto o tratamento promove a eliminação fagocítica. |
| title_auth | Neuraminidase A controls pneumococcal recognition and fate: deficiency enhances immune sensing and intracellular survival, while treatment promotes phagocytic clearance. |
| title_es_txt | La neuraminidasa A controla el reconocimiento y destino neumocócico: la deficiencia mejora la detección inmune y la supervivencia intracelular, mientras que el tratamiento promueve la eliminación fagocítica |
| title_fr_txt | La neuraminidase A contrôle la reconnaissance et le devenir du pneumocoque : la déficience améliore la détection immunitaire et la survie intracellulaire, tandis que le traitement favorise la clairance phagocytaire |
| title_full | Neuraminidase A controls pneumococcal recognition and fate: deficiency enhances immune sensing and intracellular survival, while treatment promotes phagocytic clearance. |
| title_fullStr | Neuraminidase A controls pneumococcal recognition and fate: deficiency enhances immune sensing and intracellular survival, while treatment promotes phagocytic clearance. |
| title_full_unstemmed | Neuraminidase A controls pneumococcal recognition and fate: deficiency enhances immune sensing and intracellular survival, while treatment promotes phagocytic clearance. |
| title_pt_txt | Neuraminidase A controla o reconhecimento e destino pneumocócico: a deficiência aumenta o reconhecimento imune e a sobrevivência intracelular, enquanto o tratamento promove a eliminação fagocítica. |
| title_short | Neuraminidase A controls pneumococcal recognition and fate: deficiency enhances immune sensing and intracellular survival, while treatment promotes phagocytic clearance. |
| title_sort | neuraminidase a controls pneumococcal recognition and fate: deficiency enhances immune sensing and intracellular survival, while treatment promotes phagocytic clearance. |
| topic | Allergology and Immunology General Allergology and Immunology |
| url | https://academic.oup.com/immunotherapyadv/article/doi/10.1093/immadv/ltag002/8467972?rss=1 |